DrugPatentWatch Database Preview

MINOCIN Drug Profile

« Back to Dashboard

When do Minocin patents expire, and when can generic versions of Minocin launch?

Minocin is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex Pharms. and is included in five NDAs. There are two patents protecting this drug.

This drug has thirty patent family members in twenty-two countries.

The generic ingredient in MINOCIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for MINOCIN

International Patents:	30
US Patents:	2
Applicants:	4
NDAs:	5
Suppliers / Packagers:	3
Bulk Api Vendors:	37
Clinical Trials:	35
Patent Applications:	6,634
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for MINOCIN
DailyMed Link:	MINOCIN at DailyMed

See drug prices for MINOCIN

See drug sales revenues for MINOCIN

Recent Clinical Trials for MINOCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sun Yat-sen University	Phase 2
National Jewish Health	Phase 2
University of Texas Southwestern Medical Center	Phase 2

See all MINOCIN clinical trials

Pharmacology for MINOCIN

Drug Class

Tetracycline-class Drug

Synonyms for MINOCIN

(2E,4S,4aR,5aS,12aR)-2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3 ,12-trione

(2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione

(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione

(4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione

(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE

(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

(minocycline)

10118-90-8

1071761-03-9

13614-98-7 (mono-hydrochloride)

1371-EP2269978A2

1371-EP2269985A2

1371-EP2269991A2

1371-EP2272832A1

1371-EP2284150A2

1371-EP2284151A2

1371-EP2284152A2

1371-EP2284153A2

1371-EP2284155A2

1371-EP2284156A2

1371-EP2284164A2

1371-EP2287140A2

1371-EP2287148A2

1371-EP2287150A2

1371-EP2289871A1

1371-EP2292590A2

1371-EP2292612A2

1371-EP2295402A2

1371-EP2295419A2

1371-EP2295426A1

1371-EP2295427A1

1371-EP2298732A1

1371-EP2301534A1

1371-EP2301912A2

1371-EP2301913A1

1371-EP2301914A1

1371-EP2301916A2

1371-EP2305637A2

1371-EP2308832A1

1371-EP2308863A1

1371-EP2311451A1

1371-EP2311796A1

1371-EP2311797A1

1371-EP2311798A1

1371-EP2311799A1

1371-EP2316450A1

146440-73-5

17175-40-5

18M908

2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-

2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-

24058-90-0

4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide

7-Dimethylamino-6-demethyl-6-deoxytetracycline

AB00053501_04

AB00053501_05

AB00053501-03

AC-30184

AC1L2NSN

AC1NQXWM

AC1NSG0A

AJ-65483

Akamin

Aknemin

AKOS015969674

Alti-Minocycline

AM20090714

API0003397

Apo-Minocycline

BCBcMAP01_000027

BCP9000928

BDBM50103599

Borymycin

BRN 3077644

BSPBio_002035

C07225

C23H27N3O7

CAS-10118-90-8

CHEBI:50694

CHEMBL1434

CHEMBL259172

CL 59806

D05045

DB01017

DivK1c_000450

DSSTox_CID_25033

DSSTox_GSID_45033

DSSTox_RID_80650

DTXSID1045033

DYKFCLLONBREIL-KVUCHLLUSA-N

Dynacin

FT-0628949

FYY3R43WGO

Gen-Minocycline

HMS2090D03

HSDB 3130

IDI1_000450

J-500789

KBio1_000450

KBio2_001447

KBio2_004015

KBio2_006583

KBio3_001535

KBioGR_000583

KBioSS_001447

Klinomycin

KSC-12-231B

KUC106429N

Lactoferrin B & Minocycline

Lactoferrin H & Minocycline

LMPK07000002

ls-007

LS-93850

MINO

Mino-Tabs

Minociclina

Minociclina [INN-Spanish]

minociclinum

Minocin (Hydrochloride)

Minocline

Minocyclin

minocycline

Minocycline (USAN/INN)

Minocycline [USAN:BAN:INN]

Minocycline [USAN:INN:BAN]

Minocycline Monohydrochloride

Minocyclinum

Minocyclinum [INN-Latin]

Minocyn

Minoderm

Minomycin

Minoz

MIY

MolPort-020-005-814

NCGC00178854-01

NCGC00183044-01

NCGC00188954-01

NINDS_000450

Novo-Minocycline

NSC141993

Prestwick0_000315

Prestwick1_000315

Prestwick2_000315

SBI-0051449.P003

SCHEMBL16681149

SCHEMBL24315

SCHEMBL4042

Sebomin

SMP1_000191

Solodyn

SPBio_000974

SPBio_002529

Spectrum_000967

Spectrum2_001047

Spectrum3_000508

Spectrum4_000062

Spectrum5_001293

SR-05000001675

SR-05000001675-3

Tox21_113643

Tri-minocycline

UNII-FYY3R43WGO

Vectrin

Vectrin (Hydrochloride)

ZINC100409820

ZINC14879992

ZINC4019704

US Patents and Regulatory Information for MINOCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-001	May 31, 1990	AB	RX	Yes	No
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Triax Pharms	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050315-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Rempex Pharms	MINOCIN	minocycline hydrochloride	INJECTABLE;INJECTION	050444-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes
Bausch	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-003	Feb 12, 2001		DISCN	Yes	No

International Patents for MINOCIN

Country	Patent Number	Estimated Expiration
South Africa	201208466
Colombia	6650346
China	102970992
Portugal	2568987
European Patent Office	3135289